An 11-mer Synthetic Peptide Suppressing Aggregation of Aβ25-35 and Resolving Its Aggregated Form Improves Test Performance in an Aβ25-35-Induced Alzheimer's Mouse Model

被引:0
作者
Nakamura, Rina [1 ,2 ]
Matsuda, Akira [3 ]
Higashi, Youichirou [1 ]
Hayashi, Yoshihiro [2 ,4 ]
Konishi, Motomi [5 ]
Saito, Motoaki [1 ]
Akizawa, Toshifumi [1 ,2 ]
机构
[1] Kochi Univ, Kochi Med Sch, Dept Pharmacol, Oko Cho, Kochi 7838505, Japan
[2] O Force Co Ltd, 3454 Irino Kuroshio Cho, Kochi 7891931, Japan
[3] Hiroshima Int Univ, Fac Pharmaceut Sci, Lab Med & Biochem Anal, 5-1-1 Hirokoshingai, Hiroshima 7370112, Japan
[4] Kochi Univ, Equipment Support Planning Off, Oko Cho, Kochi 7838505, Japan
[5] Setsunan Univ, Fac Pharmaceut Sci, Dept Integrat Pharm, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan
基金
日本学术振兴会;
关键词
Alzheimer's disease; amyloid-beta peptide; YS-RD11; peptide; aggregation; ThT assay; AMYLOID CASCADE HYPOTHESIS; BETA; DISEASE; PREVENTION; MEMORY; IMPAIRMENT; REDUCTION; PLAQUES;
D O I
10.3390/biom14101234
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is a high demand for the development of drugs against Alzheimer's disease (AD), which is related to the misfolding and aggregation of Amyloid-beta (A beta), due to the increasing number of patients with AD. In our present study, we aimed to assess the aggregation inhibitory effect of various synthetic YS-peptides on A beta 25-35 to identify an applicable peptide for clinical use for AD treatment and prevention. Suppression and aggregate resolution activities of YS-peptides against A beta 25-35 were evaluated using a Thioflavin T assay and scanning electron microscopy (SEM). Structure-activity relationship studies revealed that YS-RD11 (RETLVYLTHLD) and YS-RE16 (RETLVYLTHLDYDDTE) showed suppression and aggregate-resolution activities. The effect of YS-peptides on phagocytosis in microglial cells (BV-2 cells) demonstrated that YS-RD11 and YS-RE16 activated the phagocytic ability of microglia. In the A beta 25-35-induced AD mouse model, YS-RD11 prevented and improved the deficits in short-term memory. In conclusion, YS-RD11 is a suitable candidate therapeutic drug against AD and uses a strategy similar to that used for antibodies.
引用
收藏
页数:14
相关论文
共 53 条
[1]   Diastolic dysfunction in Alzheimer's disease model mice is associated with Aβ-amyloid aggregate formation and mitochondrial dysfunction [J].
Aishwarya, Richa ;
Abdullah, Chowdhury S. ;
Remex, Naznin Sultana ;
Bhuiyan, Mohammad Alfrad Nobel ;
Lu, Xiao-Hong ;
Dhanesha, Nirav ;
Stokes, Karen Y. ;
Orr, A. Wayne ;
Kevil, Christopher G. ;
Bhuiyan, Md. Shenuarin .
SCIENTIFIC REPORTS, 2024, 14 (01)
[2]   Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β [J].
Arndt, Joseph W. ;
Qian, Fang ;
Smith, Benjamin A. ;
Quan, Chao ;
Kilambi, Krishna Praneeth ;
Bush, Martin W. ;
Walz, Thomas ;
Pepinsky, R. Blake ;
Bussiere, Thierry ;
Hamann, Stefan ;
Cameron, Thomas O. ;
Weinreb, Paul H. .
SCIENTIFIC REPORTS, 2018, 8
[3]   Embelin Mitigates Amyloid-β-Induced Neurotoxicity and Cognitive Impairment in Rats: Potential Therapeutic Implications for Alzheimer's Disease [J].
Arora, Rimpi ;
Deshmukh, Rahul .
MOLECULAR NEUROBIOLOGY, 2025, 62 (02) :1577-1590
[4]   Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease [J].
Barage, Sagar H. ;
Sonawane, Kailas D. .
NEUROPEPTIDES, 2015, 52 :1-18
[5]   Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice [J].
Benjamin, Elfrida R. ;
Khanna, Richie ;
Schilling, Adriane ;
Flanagan, John J. ;
Pellegrino, Lee J. ;
Brignol, Nastry ;
Lun, Yi ;
Guillen, Darlene ;
Ranes, Brian E. ;
Frascella, Michelle ;
Soska, Rebecca ;
Feng, Jessie ;
Dungan, Leo ;
Young, Brandy ;
Lockhart, David J. ;
Valenzano, Kenneth J. .
MOLECULAR THERAPY, 2012, 20 (04) :717-726
[6]   Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease [J].
D'Agostino, Giuseppe ;
Russo, Roberto ;
Avagliano, Carmen ;
Cristiano, Claudia ;
Meli, Rosaria ;
Calignano, Antonio .
NEUROPSYCHOPHARMACOLOGY, 2012, 37 (07) :1784-1792
[7]   Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability [J].
Dahlgren, KN ;
Manelli, AM ;
Stine, WB ;
Baker, LK ;
Krafft, GA ;
LaDu, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :32046-32053
[8]   New precision medicine avenues to the prevention of Alzheimer's disease from insights into the structure and function of γ-secretases [J].
De Strooper, Bart ;
Karran, Eric .
EMBO JOURNAL, 2024, 43 (06) :887-903
[9]   Membrane dynamics of γ-secretase with the anterior pharynx-defective 1B subunit [J].
Dehury, Budheswar ;
Kepp, Kasper P. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2021, 122 (01) :69-85
[10]   Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease [J].
Doody, Rachelle S. ;
Thomas, Ronald G. ;
Farlow, Martin ;
Iwatsubo, Takeshi ;
Vellas, Bruno ;
Joffe, Steven ;
Kieburtz, Karl ;
Raman, Rema ;
Sun, Xiaoying ;
Aisen, Paul S. ;
Siemers, Eric ;
Liu-Seifert, Hong ;
Mohs, Richard .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (04) :311-321